EQS-Adhoc: QIAGEN N.V.: QIAGEN appoints Jonathan M. Pratt as Chief Executive Officer
|
EQS-Ad-hoc: QIAGEN N.V. / Key word(s): Personnel decisions / Executive Board/Strategic corporate decision Ad hoc Announcement according to Art. 17 Market Abuse Regulation
QIAGEN appoints Jonathan M. Pratt as Chief Executive Officer Venlo, the Netherlands, August 24, 2026 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announces that Jonathan M. Pratt has been appointed Chief Executive Officer, effective September 1, 2026. He brings to QIAGEN more than 25 years of international leadership experience across life sciences, laboratory technologies and healthcare. Jon Pratt most recently served as President and CEO of Filtration Group, leading the business through the completion of its sale to Parker-Hannifin Corporation in August 2026. He previously served as Senior Vice President of the Waters Division at Waters Corporation and as President of Beckman Coulter Life Sciences, a Danaher operating company, and held senior leadership positions at Pall Corporation. Throughout his career, he has led global businesses spanning analytical instruments, laboratory technologies, software, consumables, services and bioprocessing applications. His experience includes commercial execution, portfolio management, operations and organizational development in markets closely aligned with QIAGEN’s portfolio and customer workflows. He will also be proposed for shareholder approval as a Managing Director at an Extraordinary General Meeting planned for the fourth quarter of 2026. Thierry Bernard will step down as CEO and Managing Director and will support an orderly transition through the end of the year. QIAGEN has reaffirmed its outlook for the third quarter and full-year 2026. QIAGEN remains focused on delivering solid profitable growth by advancing its growth pillars, improving operating efficiency and allocating capital to the highest-return opportunities. As previously communicated, the Supervisory Board continues to evaluate opportunities, with independent financial and legal advisors, as part of its strategic review to create value for shareholders and other stakeholders relative to QIAGEN’s standalone business plan and long-term strategic objectives. QIAGEN N.V. Hulsterweg 82 5912 PL Venlo The Netherlands
Ad hoc ISIN: NL0015001WM6 Frankfurt Stock Exchange, Regulated Market (Prime Standard)
Contacts QIAGEN N.V. Corporate Communications John Gilardi, Tel: +49 2103 29 11711; pr@qiagen.com End of Inside Information
24-Aug-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | QIAGEN N.V. |
| Hulsterweg 82 | |
| 5912 PL Venlo | |
| Netherlands | |
| Phone: | +31 7735566 - 00 |
| Fax: | +31 77 35566-58 |
| E-mail: | qiagen@qiagen.com |
| Internet: | www.qiagen.com |
| ISIN: | NL0015002SN0 |
| WKN: | A41HBE |
| Indices: | DAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Tradegate BSX; Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart; London, Chicago, NYSE, SIX |
| LEI Code: | 54930036WK3GMCN17Z57 |
| EQS News ID: | 2387768 |
| End of Announcement | EQS News Service |
|
|
2387768 24-Aug-2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 1.527,26 | 1.985,15 | 2.007,10 | 1.780,48 | 1.898,98 | 1.930,00 | 0,00 | |
| EBITDA1,2 | 482,95 | 753,93 | 697,99 | 565,68 | 288,92 | 0,00 | 0,00 | |
| EBITDA-Margin3 | 31,62 | 37,98 | 34,78 | 31,77 | 15,21 | 0,00 | 0,00 | |
| EBIT1,4 | 315,55 | 560,44 | 499,50 | 374,22 | 93,80 | 0,00 | 0,00 | |
| EBIT-Margin5 | 20,66 | 28,23 | 24,89 | 21,02 | 4,94 | 0,00 | 0,00 | |
| Net Profit (Loss)1 | 293,30 | 473,49 | 539,15 | 439,21 | 80,24 | 0,00 | 0,00 | |
| Net-Margin6 | 19,20 | 23,85 | 26,86 | 24,67 | 4,23 | 0,00 | 0,00 | |
| Cashflow1,7 | 373,83 | 595,98 | 703,48 | 446,44 | 646,57 | 0,00 | 0,00 | |
| Earnings per share8 | 1,25 | 2,31 | 2,34 | 1,90 | 0,36 | 1,80 | 2,03 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,22 | 0,25 | 0,25 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: KPMG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Qiagen | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A41HBE | NL0015002SN0 | N.V. | 7.497,56 Mio € | 25.09.1997 | Halten | 9F385X9M+R4 |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 17,26 | 23,20 | 0,74 | 28,19 | 2,22 | 11,60 | 3,95 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,22 | 0,25 | 0,69% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 24.06.2026 | 28.04.2026 | 05.08.2026 | 13.11.2025 | 05.02.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +3,99% | -1,20% | -6,21% | -14,89% | +1.124,79% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
